← SynDRA
METHYL AMINOLEVULINATE
SynDRA canonical compound SYN0021752 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | FCGR1A | FECH |
|---|
| Mechanism of action | oxidizing agent |
|---|
| Indication | actinic keratosis (AK) |
|---|
| Disease area | dermatology |
|---|
All known targets
Mechanisms of action (all sources)
- oxidizing agent
- FECH ACTIVATOR
Drug classes
- Porphyrin Precursor
- Photosensitizing Agents
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- aminolevulinic acid methyl ester
- 5-Amino-4-oxopentanoic acid methyl ester
- methyl aminolevulinate hydrochloride
- methyl aminolevulinate HCl
- Methyl 5-aminolevulinate
- Methyl aminolaevulinate
- Methylaminolevulinate
- Metvix
- Aminolevulinic acid methyl ester
- Methyl delta-aminolevulinate
- Methyl5-amino-4-oxopentanoate
- Levulinic acid, 5-amino-, methyl ester
- Pentanoic acid, 5-amino-4-oxo-, methyl ester
- 5-Aminolevulinic acid methyl ester
- methyl 5-amino-4-oxopentanoate
- Methyl-5-aminolevulinate
- methyl aminolaevulinate
- methyl delta-aminolevulinate
- MAOP cpd
- CHEBI:724125
- RefChem:157787
- DTXCID4028202
- NCGC00018251-03
- UNII-585NM85KYM
- methyl5-amino-4-oxopentanoate
- SCHEMBL8521
- 5-Aminolavulinsauremethylester
- orb1706138
- YUUAYBAIHCDHHD-UHFFFAOYSA-N
- METHYL AMINOLEVULINATE [MI]
- HY-A0169
- EBC-26088
- METHYL AMINOLEVULINATE [VANDF]
- AKOS006220489
- METHYL AMINOLEVULINATE [WHO-DD]
- NCGC00018251-01
- NCGC00018251-02
Reported adverse events
- Blister
- Burning sensation
- Erythema
- Pain
- Pruritus
- Skin infection
- Skin ulcer
Look up METHYL AMINOLEVULINATE in the interactive SynDRA portal →